Antoaneta Bukasa
- Pharmacology top 0.5%
- Biochemistry top 2%
- Blood transfusion and management 2
- Pharmacology top 5%
- Equine top 10%
- Modeling and Simulation top 5%
-
- Virology and Viral Diseases 6
- Respiratory viral infections research 2
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 4
-
- Vaccine Coverage and Hesitancy 5
-
- Syphilis Diagnosis and Treatment 3
-
- Platelet Disorders and Treatments 2
- Co-authors
- Jane A. MitchellJohn R. VaneIvana VojnovicFrancesco GiulianoTimothy D. WarnerMary RamsayKevin BrownNick Andrews
- Cited by
- PharmacologyBiochemistry
- Journals
- Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (1 paper)Emerging infectious diseases (2 papers)
- Partner nations
- United Kingdom
In The Last Decade
Antoaneta Bukasa
16 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Pharmacology 963
- Biochemistry 177
- Pharmacology 155
- Equine 15
- Modeling and Simulation 41
Countries citing papers authored by Antoaneta Bukasa
This map shows the geographic impact of Antoaneta Bukasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoaneta Bukasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoaneta Bukasa more than expected).
Fields of papers citing papers by Antoaneta Bukasa
This network shows the impact of papers produced by Antoaneta Bukasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoaneta Bukasa. The network helps show where Antoaneta Bukasa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antoaneta Bukasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 52 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 32 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 1 | |
| 8 | 2019 | 8 | |
| 9 | 2018 | 15 | |
| 10 | 2016 | 13 | |
| 11 | 2014 | 22 | |
| 12 | 2011 | 47 | |
| 13 | 2010 | 16 | |
| 14 | 2002 | 4 | |
| 15 | 2002 | 2 | |
| 16 | Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisbreakdown → | 1999 | 1260 |
About Antoaneta Bukasa
Antoaneta Bukasa is a scholar working on Health, Biochemistry and Infectious Diseases, having authored 16 papers that have together received 1.5k indexed citations. Recurring topics across this work include Virology and Viral Diseases (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Vaccine Coverage and Hesitancy (5 papers), COVID-19 Clinical Research Studies (4 papers), Syphilis Diagnosis and Treatment (3 papers), Respiratory viral infections research (2 papers), Platelet Disorders and Treatments (2 papers) and Blood transfusion and management (2 papers). The work is most often cited by research in Pharmacology (963 citations), Biochemistry (177 citations) and Pharmacology (155 citations). Antoaneta Bukasa has collaborated with scholars based in United Kingdom. Frequent co-authors include Jane A. Mitchell, John R. Vane, Ivana Vojnovic, Francesco Giuliano, Timothy D. Warner, Mary Ramsay, Kevin Brown, Nick Andrews, Helen Campbell and Chee‐Fu Yung. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.